Literature DB >> 1626772

Hematologic and serum biochemical effects of long-term administration of anti-inflammatory doses of prednisone in dogs.

G E Moore1, E A Mahaffey, M Hoenig.   

Abstract

Results of routine hematologic and serum biochemical analyses from 12 healthy adult male dogs that were given prednisone (0.55 mg/kg of body weight, PO, q 12 h) for 35 days were compared with those of a control group of 6 dogs that were given gelatin capsules. Analyses were performed at 2-week intervals during and after prednisone administration. Lymphocyte and eosinophil counts were significantly (P less than 0.005) decreased after 2 and 4 weeks of prednisone treatment, compared with controls. Two weeks after treatment, eosinophil counts in prednisone-treated dogs were similar to those of control dogs, whereas lymphocyte counts remained low 4 weeks after treatment in treated dogs (1,869 +/- 145 cells/microliters), compared with that in control dogs (3,662 +/- 548 cells/microliters). Neutrophil and monocyte counts did not significantly change during glucocorticoid administration. Mean platelet volume significantly (P less than 0.001) decreased after 4 weeks of prednisone treatment, but returned to pretreatment values by 2 weeks after treatment. Four weeks of prednisone treatment did not cause significant increased activity in serum alanine transaminase, total alkaline phosphatase or the steroid-induced isoenzyme of alkaline phosphatase. Significant increases in serum albumin (P less than 0.001) and total protein (P less than 0.05) concentrations were detected after 4 weeks of treatment, but mean values were not significantly different from those of controls 2 weeks after treatment ended. Results of our study indicate that eosinophil and lymphocyte counts are the most sensitive indicators of long-term glucocorticoid administration at anti-inflammatory dosages of 1.1 mg/kg daily.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626772

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Serum C-reactive protein and immune responses in dogs inoculated with Bordetella bronchiseptica (phase I cells).

Authors:  S Yamamoto; T Shida; M Honda; Y Ashida; Y Rikihisa; M Odakura; S Hayashi; M Nomura; Y Isayama
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

2.  Hemodynamic and biochemical alterations in dogs with lymphoma after induction of chemotherapy.

Authors:  D M Fine; K Selting; R C Backus; N F Rossi; M W Harmon; H E Durham; A W Spier
Journal:  J Vet Intern Med       Date:  2014-03-21       Impact factor: 3.333

3.  Mathematical Modelling Using Predictive Biomarkers for the Outcome of Canine Leishmaniasis upon Chemotherapy.

Authors:  Rafaela de Sousa Gonçalves; Flaviane Alves de Pinho; Ricardo Jorge Dinis-Oliveira; Rui Azevedo; Joana Gaifem; Daniela Farias Larangeira; Eduardo Milton Ramos-Sanchez; Hiro Goto; Ricardo Silvestre; Stella Maria Barrouin-Melo
Journal:  Microorganisms       Date:  2020-05-15

4.  Mitotane (o,p'-DDD) treatment in a cat with hyperadrenocorticism.

Authors:  C S Schwedes
Journal:  J Small Anim Pract       Date:  1997-11       Impact factor: 1.522

5.  Thrombocytosis in 715 Dogs (2011-2015).

Authors:  A D Woolcock; A Keenan; C Cheung; J A Christian; G E Moore
Journal:  J Vet Intern Med       Date:  2017-09-12       Impact factor: 3.333

6.  Prednisolone in Dogs-Plasma Exposure and White Blood Cell Response.

Authors:  Carl Ekstrand; Helena Pettersson; Ronette Gehring; Mikael Hedeland; Sara Adolfsson; Inger Lilliehöök
Journal:  Front Vet Sci       Date:  2021-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.